Phage therapy is a viable alternative to antibiotics for treating microbial infections, particularly managing drug-resistant strains of bacteria. One of the major challenges in designing phage based therapy is to identify the most appropriate phage to treat a bacterial infection. In this study, an attempt has been made to predict phage-host interaction with high accuracy to identify the best virus for treating a bacterial infection. All models have been developed on a training dataset containing 826 phage host-interactions, whereas models have been evaluated on a validation dataset comprising 1201 phage-host interactions. Firstly, alignment based models have been developed using similarity between phage-phage (BLASTPhage), host-host (BLASTHost) and phage-CRISPR (CRISPRPred) where we achieved accuracy between 42.4%-66.2% for BLASTPhage, 55%-78.4% for BLASTHost, and 43.7%-80.2% for CRISPRPred at five taxonomic levels. Secondly, alignment free models have been developed using machine learning techniques. Thirdly, hybrid models have been developed by integrating alignment-free models and similarity-score where we achieved maximum performance of (60.6%-93.5%). Finally, an ensemble model has been developed that combines hybrid and alignment based model. Our ensemble model achieved highest accuracy of 67.9%, 80.6%, 85.5%, 90%, 93.5% at Genus, Family, Order, Class and Phylum levels, which is better than existing methods. In order to serve the scientific community we have developed a webserver named PhageTB and standalone software package (https://webs.iiitd.edu.in/raghava/phagetb/).Key PointsPhage therapy provides an alternative to mange drug resistant strains of bacteriaPrediction bacterial strains that can be treated by a given phageAlignment-based, alignment-free and ensemble models have been developed.Prediction of appropriate phage/virus that can lyse a given strain of bacteria.Webserver and standalone package provided to predict phage-host interactions.

Phage therapy is a viable alternative to antibiotics for treating microbial infections, particularly managing drug-resistant strains of bacteria. One of the major challenges in designing phage-based therapy is to identify the most appropriate potential phage candidate to treat bacterial infections. In this study, an attempt has been made to predict phage-host interactions with high accuracy to identify the potential bacteriophage that can be used for treating a bacterial infection. The developed models have been created using a training dataset containing 826 phage- host interactions, and have been evaluated on a validation dataset comprising 1,201 phage-host interactions. Firstly, alignment-based models have been developed using similarity between phage-phage (BLASTPhage), host–host (BLASTHost) and phage-CRISPR (CRISPRPred), where we achieved accuracy between 42.4–66.2% for BLASTPhage, 55–78.4% for BLASTHost, and 43.7–80.2% for CRISPRPred across five taxonomic levels. Secondly, alignment free models have been developed using machine learning techniques. Thirdly, hybrid models have been developed by integrating the alignment-free models and the similarity-scores where we achieved maximum performance of (60.6–93.5%). Finally, an ensemble model has been developed that combines the hybrid and alignment-based models. Our ensemble model achieved highest accuracy of 67.9, 80.6, 85.5, 90, and 93.5% at Genus, Family, Order, Class, and Phylum levels on validation dataset. In order to serve the scientific community, we have also developed a webserver named PhageTB and provided a standalone software package (https://webs.iiitd.edu.in/raghava/phagetb/) for the same.

In the current era, one of the major challenges is to manage the treatment of drug/antibiotic-resistant strains of bacteria. Phage therapy, a century-old technique, may serve as an alternative to antibiotics in treating bacterial infections caused by drug-resistant strains of bacteria. In this review, a systematic attempt has been made to summarize phage-based therapy in depth. This review has been divided into the following two sections: general information and computer-aided phage therapy (CAPT). In the case of general information, we cover the history of phage therapy, the mechanism of action, the status of phage-based products (approved and clinical trials) and the challenges. This review emphasizes CAPT, where we have covered primary phage-associated resources, phage prediction methods and pipelines. This review covers a wide range of databases and resources, including viral genomes and proteins, phage receptors, host genomes of phages, phage–host interactions and lytic proteins. In the post-genomic era, identifying the most suitable phage for lysing a drug-resistant strain of bacterium is crucial for developing alternate treatments for drug-resistant bacteria and this remains a challenging problem. Thus, we compile all phage-associated prediction methods that include the prediction of phages for a bacterial strain, the host for a phage and the identification of interacting phage–host pairs. Most of these methods have been developed using machine learning and deep learning techniques. This review also discussed recent advances in the field of CAPT, where we briefly describe computational tools available for predicting phage virions, the life cycle of phages and prophage identification. Finally, we describe phage-based therapy’s advantages, challenges and opportunities.